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Postpartum hemorrhage (PPH) is still the most important
and potentially avoidable cause of maternal death (1). The
uterus in late pregnancy or at term has at any moment a
through-flow of blood that corresponds to approximately
one-sixth of the pregnant woman’s total blood volume, set-
ting the scene for massive bleeding from up to 200 dilated
spiral arteries into the uterine cavity, if the uterus does not
retract and contract as expected. Hemorrhage ensues, which
in a short time may lead to death of a woman in the prime
of her life – death at a time when she is supposed to be
healthy and able to tolerate more than at other ages. The
rapidity of blood loss often goes unnoticed until the situation
starts to deteriorate. If the patient is weak and anemic like
many women are in low-resource countries, if she is poorly
nourished as may easily be seen in the supposedly richer
societies, or if she is in the wrong type of delivery situation
where background services and transport are inadequate, the
danger of severe morbidity and even death is real. There are
good reasons why the overwhelming numbers of maternal
deaths from severe PPH have stimulated initiatives from
regional and international organizations to try to prevent and
limit the serious effects of postpartum hemorrhage.
Clinical improvement activities have mainly focused on
medical treatment of uterine atony. In 2003 at the FIGO con-
ference in Santiago, Chile, the two professional organizations
FIGO (International Federation of Gynecology and
Obststerics) and the ICM (International Confederation of
Midwives) launched a global initiative to combat maternal
death from PPH (2,3). Since there was evidence that active
management of the third stage reduced the incidence of PPH,
the quantity of blood loss and the use of blood transfusion,
the two organizations agreed that active management of the
third stage should be offered to all women. This involved
administration of uterotonic drugs, controlled cord traction
and uterine massage following delivery of the placenta.
However, the retained placenta and abnormally invasive
placenta (AIP) present a different problem where uterine
atony may persist along with incomplete separation and thus
continued bleeding from a varying and always unknown
number of large vessels in the placental bed. The most com-
mon form of a retained placenta may not respond effectively
to medical treatment and after a while result in atony and
bleeding. Which is the best approach to the common retained
placenta? For how long should we wait before proceeding to
manual evacuation? Giel van Stralen and colleagues in Leiden,
Amsterdam and Den Haag, Netherlands (pp. 396–402), Sys
Nikolajsen and co-workers in Hillerød, Denmark (pp. 419–423)
and Vedran Stefanovic and colleagues in Helsinki, Finland
(pp. 424–431) present new data on the clinical management
of retained placenta with different results and conclusions.
Therefore, and for the paucity of evidence-based literature on
this topic, we aim to call for large observational and random-
ized controlled studies on retained placenta and PPH. One
example is the postpartum use of ultrasound when there is a
retained placenta. Can ultrasound be used to differ between
an entrapped placenta that should be removed manually and
AIP, where a quite different management approach is needed?
After studying this issue of AOGS, you will agree that this is
possible. Furthermore, the prenatal suspicion of AIP is
important because that alone will reduce the maternal
morbidity, as reported by Frederic Chantraine and a consor-
tium of co-workers in Belgium, Germany and Switzerland
(pp. 437–442).
Retention of bits and pieces of the placenta or membranes
may result in atony, which initially is somewhat responsive to
uterotonics, but where hemorrhage will eventually recur in a
situation when the mother is lactating, enjoying her first meal
and the family is celebrating. Therefore, the management for
PPH starts with a clinical examination (inspection of vulva,
vagina and cervix) and exploration of the uterine cavity,
either by manual revision or ultrasound. In addition to the
medical treatment, Bakri balloon tamponade must also be
considered as a rapid and effective option where applicable.
The results presented by Maiju Gr€onvall and co-workers in
Helsinki, Finland (pp. 431–436) and Laura Aibar and col-
leagues in Granada and Motril, Spain (pp. 463–465), are
encouraging.
All women with retained placenta do potentially need anes-
thesia. These women need to be prioritized because an unnec-
essary delay will inevitably result in more blood loss (4). Close
collaboration with a view “to make plans” in a team formed
by obstetricians, anesthetists and midwives is necessary for
these situations. Practical consideration of all eventualities is
essential since the quantity of PPH is very time dependent. In
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this stressful situation, a team can even “forget” to apply trans-
fusion guidelines as reported by Marie Bonnet and colleagues in
Paris, Lyon, and Bron, France (pp. 402-411). Continuous train-
ing of all the disciplines in touch with PPH and AIP situations
has to be developed by each unit. Regular auditing may help to
keep the required high level of competence.
How do we then diagnose and manage the most severe
forms of AIP, also known as placenta percreta, which are rare,
but unavoidably going to increase due to the “cesarean epi-
demic”? Prediction of severe AIP relies on competent screen-
ing by ultrasound, especially in women with a previous
cesarean section and a low anterior placenta. Implantation
may result in a “cesarean scar pregnancy” or a “placenta per-
creta” either covering a uterine lower segment dehiscence or
invading the scar tissue (5). Placental tissue is by nature inva-
sive and stimulated by hypoxia to invade deeply (scar tissue
is worse for blood connections) and here it may go through
the scar to seek angio-connection in a neighboring organ,
usually the bladder, since severely invasive placentas are most
often localized in a previous isthmic cesarean scar. Then we
have an even more serious issue where it may be impossible
to remove the pathologic tissue without excessive trauma. To
manage such cases effectively, a multidisciplinary team in a
tertiary care center treating these conditions regularly is vital.
Caroline Clausen and her colleagues in Copenhagen, Den-
mark (pp. 384–389) demonstrate clearly by the example of
balloon occlusion of the iliac arteries the need for expertise in
the management of severe AIP cases.
It can be foreseen that tertiary advice centers can also
come in with telecommunication measures to help with the
difficult surgery invariably inherent in such a situation, – in
order to give advice on what to do, how to do it and when
to stop. To obtain an optimal structure for the management
of women with severe AIP, we need preparation in the place
of delivery and explicit and clear referral plans to centers of
excellence on a regional or even inter-country basis with
video- and telephone links for efficient access to expert
knowledge. The need for collaboration between specialties
cannot be exaggerated. This calls for education by multidisci-
plinary courses and for training activities for key obstetri-
cians, midwives and specialists in anesthesia, fetal medicine,
blood-banking, and interventional radiology.
Just over a year ago we put out a call for articles on AIP.
We had more than could be published in one issue, which
shows the interest and importance of this topic worldwide.
Most are here and reflect anything from operative methodol-
ogy to a conservative approach, each with their merits and
limits, as no one has the all-embracing answer. More will
appear in the next issues of AOGS. We hope this volume
will reflect the broadness of medical interest and concern
and lead to practical proposals and solutions like at FIGO in
2003; only here it is not just midwives and obstetricians like
with atonic PPH. A broad collaboration with other medical
specialties is called for as well.
The main goal is to minimize the serious, dramatic and
even fatal consequences of postpartum hemorrhage. Uterine
atony is important, and the abnormally invasive placenta as
well. While continuing to forestall uterine atony, the focus
should now shift to severe AIP. In these years international
networks and collaborative data collection are being
launched to solve important research questions in this field.
Examples are NOSS (Nordic Obstetric Surveillance System),
UKOSS (UK Obstetric Surveillance System) and now the
EW-AIP (European Working Group on AIP) initiatives. The
French PACCERTA-project, a prospective population-based
study on AIP presented in this issue by Gilles Kayem and
co-workers at centers in France (pp. 474–480), highlights the
right direction for clinical research in this field.
This theme issue covers a broad range of studies, shows
novel surgical techniques and provides dramatic narratives!
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Consider attending at:
The 4th Nordic Endometriosis Congress (NCE2013) in Turku, Finland on 23.-25. May (www.NCE2013.fi).
The ISSHP European Congress is in Troms€o, Norway, 12.-14. June (International Society for the Study of Hyper-
tension in Pregnancy, www.isshp.org).
The 10th congress of the European Society of Gynecology, Bruxelles, Belgium 18-21 September 2013 (www.
seg2013.com)
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